| 供应商 | 上海晅科生物科技有限公司 |
| 数量 | 100 |
| 靶点 | 详询 |
| 级别 | 科研 |
| 目录编号 | XK-KYKT-3953 |
| 克隆性 | 多克隆 |
| 抗原来源 | KLH conjugated synthetic peptide derived from human CCL15:31-113/113 |
| 保质期 | 24个月 |
| 抗体英文名 | Anti-CCL15 |
| 抗体名 | 巨噬细胞炎性蛋白15 |
| 标记物 | 详询 |
| 宿主 | Rabbit |
| 适应物种 | Human, |
| 免疫原 | KLH conjugated synthetic peptide derived from human CCL15:31-113/113 |
| 亚型 | IgG |
| 形态 | Lyophilized or Liquid |
| 应用范围 | ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 浓度 | 1mg/ml |
| 保存条件 | -20℃ |
| 规格 | 100ul/200ul |
| anti-ASPP1（apoptosis stimulating protein of P53 1）p53凋亡刺激蛋白1抗体 | |
| anti-ASPP2（apoptosis stimulating protein of P53 2）P53凋亡刺激蛋白2 | |
| Anti-AT/AGT（Angiotenogen）血管紧张素原抗体 | |
| Anti-AT1R（Angiotensin II Type 1 Receptor）血管紧张素Ⅱ-1型受体抗体 | |
| Anti-ATF1 (Activating Transcription Factor1)活化复制因子1抗体 | |
| Anti-ATF2 (Activating Transcription Factor2)活化复制因子2抗体 | |
| Anti-ATF3 (Activating Transcription Factor3)活化转录因子3抗体 | |
| Anti-B7-H1/PDL1/CD274(programmed death ligand 1)程序性死亡配体1抗体 | |
| Anti-B7-H4 ( V-set domain containing T cell activation inhibitor 1 )B7H4抗体 | |
| Anti-BACE/ASP2β分泌酶抗体 | |
| Anti-Bad (BCL-xL/BCL-2-associated death promoter)相关死亡促进因子Bad抗体 | |
| anti-Bak（BCL2 homologous antagonist/killer）Bcl-2同源拮抗剂Bak抗体 | |
| Anti-BADH2 (Betaine-aldehyde dehydrogenase )BADH2抗体 | |
| Anti-Bassoon/YTN(zinc finger protein)锌指蛋白231抗体 | |
| Anti-Bax （Bcl-2 Assaciated X protein）Bax（小鼠来源抗体） | |
| Anti-Bax（Bcl-2 Assaciated X protein）Bax抗体 | |
| Anti-Bcl-2(B cell lymphoma/leukemia-2)Bcl-2抗体 | |
